You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

capmatinib

Showing 1 - 25 of 27
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Tabrecta® (Capmatinib) in South Korea

Not yet recruiting
  • Non-Small-Cell Lung Carcinoma
  • Capmatinib
  • (no location specified)
Jan 19, 2023

NSCLC Trial in Pittsburgh (Capmatinib)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • Capmatinib
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Jan 9, 2023

Oesophageal Adenocarcinoma, Gastric Adenocarcinoma Trial in France (Capmatinib, Spartalizumab)

Suspended
  • Oesophageal Adenocarcinoma
  • Gastric Adenocarcinoma
  • Besançon, France
  • +6 more
Feb 1, 2023

Metastatic NSCLC MET Exon 14 Skipping Mutation and Brain

Completed
  • Metastatic Non-Small Cell Lung Cancer
  • Capmatinib
  • East Hanover, New Jersey
    18 Novartis Investigative Sites in the US
Dec 29, 2022

Non-Small Cell Lung Carcinoma Trial (Capmatinib 150 mg, Capmatinib 200 mg)

Recruiting
  • Non-Small Cell Lung Carcinoma
  • Capmatinib 150 mg
  • Capmatinib 200 mg
  • Guwahati, Assam, India
  • +7 more
Dec 19, 2022

Metastatic Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer Trial in San Francisco (Capmatinib, Trametinib)

Recruiting
  • Metastatic Lung Non-Small Cell Carcinoma
  • Stage IV Lung Cancer
  • San Francisco, California
    University of California San Francisco
Aug 15, 2022

NSCLC Trial in Japan, Korea, Republic of, Singapore (capmatinib, pemetrexed, cisplatin)

Terminated
  • Carcinoma, Non-Small-Cell Lung
  • capmatinib
  • +4 more
  • Kashiwa, Chiba, Japan
  • +3 more
Jan 31, 2023

Capmatinib vs. Standard of Care for German Adult Locally

Completed
  • Locally Advanced or Metastatic Non-Small Cell Lung Cancer Harboring METex14 Mutations
    • Berlin, Germany
    • +9 more
    Mar 22, 2023

    Malignant Non-small Cell Tumor of Lung Stage IV Trial in Boston (Capmatinib (INC280))

    Completed
    Has Results
    • Malignant Non-small Cell Neoplasm of Lung Stage IV
    • Capmatinib (INC280)
    • Boston, Massachusetts
      Massachusetts General Hospital
    Mar 11, 2022

    NSCLC Trial in United States (capmatinib)

    Recruiting
    • Non-small Cell Lung Cancer
    • capmatinib
    • La Jolla, California
    • +7 more
    Oct 5, 2022

    Advanced Solid Tumors Which Are cMET-dependent Trial in Worldwide (Capmatinib, Nazartinib, Gefitinib)

    Recruiting
    • Advanced Solid Tumors Which Are cMET-dependent
    • Capmatinib
    • +3 more
    • Boston, Massachusetts
    • +12 more
    Jan 27, 2023

    NSCLC (NSCLC) Trial in China (Capmatinib)

    Recruiting
    • Non-Small Cell Lung Cancer (NSCLC)
    • Capmatinib
    • Xiamen, Fujian, China
    • +18 more
    Jan 27, 2023

    Metastatic Breast Cancer, Breast Cancer Trial in Houston (Neratinib, Capmatinib)

    Not yet recruiting
    • Metastatic Breast Cancer
    • Breast Cancer
    • Houston, Texas
      M D Anderson Cancer Center
    Feb 16, 2022

    Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial (procedure, drug, biological)

    Not yet recruiting
    • Recurrent Lung Non-Small Cell Carcinoma
    • Stage IV Lung Cancer AJCC v8
    • Biospecimen Collection
    • +5 more
    • (no location specified)
    Nov 30, 2022

    NSCLC Trial in Worldwide (Capmatinib, Spartalizumab, Docetaxel)

    Completed
    Has Results
    • Carcinoma, Non-Small-Cell Lung
    • Capmatinib
    • +2 more
    • Fayetteville, Arkansas
    • +7 more
    Jan 21, 2022

    NSCLC, BRAF V600 Mutation, MET Exon 14 Mutation Trial in Guangzhou (Dabrafenib + Trametinib, Capmatinib)

    Not yet recruiting
    • NSCLC
    • +2 more
    • Dabrafenib + Trametinib
    • Capmatinib
    • Guangzhou, Guangdong, China
      Cancer Center of Sun-Yat Sen University
    Sep 19, 2023

    Carcinoma, Non-Small Cell Lung, NSCLC, Non-Small-Cell Lung Carcinoma Trial (Capmatinib)

    Available
    • Carcinoma, Non-Small Cell Lung
    • +3 more
    • Capmatinib
    • (no location specified)
    Aug 31, 2021

    NSCLC Trial in Worldwide (Capmatinib, Amivantamab)

    Not yet recruiting
    • Carcinoma, Non-Small-Cell Lung
    • Orange, California
    • +40 more
    Aug 3, 2022

    Non Small Cell Lung Cancer Trial in Worldwide (Capmatinib, Nazartinib)

    Terminated
    • Non Small Cell Lung Cancer
    • Boston, Massachusetts
    • +18 more
    Jul 20, 2022

    Soft Tissue Sarcoma Trial in France (drug, combination product, other)

    Recruiting
    • Soft Tissue Sarcoma
    • Bordeaux, France
    • +17 more
    Oct 4, 2022

    ALK Fusion Protein Expression, BRAF wt Allele, Invasive Skin Melanoma Trial in San Francisco (Capmatinib, Ceritinib,

    Terminated
    Has Results
    • ALK Fusion Protein Expression
    • +14 more
    • Capmatinib
    • +4 more
    • San Francisco, California
      University of California, San Francisco
    Jan 14, 2020

    NSCLC Trial in Worldwide (INC280, Gefitinib)

    Completed
    Has Results
    • Non-small Cell Lung Cancer
    • Woolloongabba, Queensland, Australia
    • +30 more
    Mar 12, 2021

    Cancer Metastatic Trial in Norway (Atezolizumab)

    Recruiting
    • Cancer Metastatic
    • Bergen, Norway
    • +16 more
    Oct 24, 2022

    NSCLC Trial in Worldwide (INC280 (capmatinib))

    Active, not recruiting
    • Carcinoma, Non-Small-Cell Lung
    • INC280 (capmatinib)
    • Long Beach, California
    • +95 more
    Dec 29, 2022

    Cancer, Lung Cancer Metastatic, MET Gene Mutation Trial in Seoul (Capmatinib)

    Unknown status
    • Cancer
    • +2 more
    • Capmatinib
    • Seoul, Korea, Republic of
      Asan Medical Center
    Oct 1, 2018